This move is archived. Current quotes and coverage live on the stock page.
Get CHLT alerts:
Custom Health Holdings Inc. is facing a downturn despite recent positive developments.
Custom Health Holdings Inc. (TSX:CHLT) is experiencing a notable decline in its stock price, down 2.96% today to CA$6.89. This drop comes despite recent positive news, including a Buy rating from Stifel and a significant acquisition that could enhance its revenue potential.
Investor takeaway: Investors should be cautious as Custom Health's stock struggles to maintain momentum amidst a broader market context that may be affecting sentiment.
Advertisement
Custom Health Holdings Inc.
CHLT.TO
CHLT.TO
Custom Health Holdings Inc.
WealthAwesomeMarket cap
$186.12M
52W high
$11.00
52W low
$5.25
1W change
+5.26%
Analyst Price Targets
Based on analyst covering CHLT
Wall Street analysts forecast CHLT stock price to rise 66.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$12.00
+66.7% Upside
Current Price
C$7.20
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CHLT's historical volatility
30-Day Vol
69.4%
Annualized
90-Day Vol
98.9%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$6.02
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$6.78 | C$5.34 โ C$8.62 |
| 60 trading days | C$6.39 | C$4.56 โ C$8.97 |
| 90 trading days | C$6.02 | C$3.98 โ C$9.12 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
CA$6.89
Custom Health's market cap stands at CA$183.5 million, reflecting the challenges it faces in gaining investor traction.
Bull case
Even with the current decline, Custom Health's innovative approach to medication adherence and its recent acquisition of Evergreen Pharmacy could lead to significant growth opportunities in the long run. This acquisition is expected to add over US$78 million in annual revenue, which could strengthen its market position.
Bear case
The stock's decline today raises concerns about investor confidence. Broader market trends may be influencing this sentiment, along with questions about the company's ability to execute its growth strategy effectively. Investors are understandably cautious given the current volatility in the healthcare sector.
Advertisement
Recent Developments
Custom Health recently secured a Buy rating from Stifel, which set a price target of CA$12, indicating significant upside potential. However, despite these promising developments, Custom Health's stock is down today. This decline may reflect broader market trends or investor skepticism regarding the company's ability to capitalize on its recent initiatives. The market's reaction underscores the volatility that can accompany growth stocks, especially in the healthcare sector.
Looking Ahead
Investors should monitor how Custom Health navigates this challenging period. The company's focus on improving medication adherence through innovative technology could prove beneficial in the long run, but its immediate stock performance raises questions about market confidence and execution risk.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile โโ Reviewed by Certified Financial Professionals
This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
โ ๏ธ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
